Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MRNA-1230 by Moderna for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
MRNA-1230 is under clinical development by Moderna and currently in Phase I for Respiratory Syncytial Virus (RSV) Infections. According to...
Data Insights
MRNA-1230 by Moderna for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
MRNA-1230 is under clinical development by Moderna and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...